THIENOPYRROLE COMPOUNDS

The present disclosure relates generally to thioeno[3, 2-], pyrrole derivatives pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions provided herein may be used for the treatment or preve...

Full description

Saved in:
Bibliographic Details
Main Authors CANALES, EDA Y, KINFE, HENOK H, MITCHELL, MICHAEL L, SHORE, DANIEL G, CODELLI, JULIAN A, JIANG, LAN, SCHROEDER, SCOTT D, AMMANN, STEPHEN E, LAZERWITH, SCOTT E, CHANG, WENG K
Format Patent
LanguageEnglish
French
Published 18.08.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates generally to thioeno[3, 2-], pyrrole derivatives pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions provided herein may be used for the treatment or prevention of an autoimmune disease and/or inflammatory condition, including systemic lupus erythematosus and cutaneous lupus erythematosus. La présente divulgation concerne d'une manière générale des dérivés de thioeno[3,2-],pyrrole, des compositions pharmaceutiques comprenant lesdits composés, et des procédés de fabrication et d'utilisation desdits composés et desdites compositions pharmaceutiques. Les composés et les compositions de l'invention peuvent être utilisés pour le traitement ou la prévention d'une maladie auto-immune et/ou d'une affection inflammatoire, comprenant le lupus érythémateux disséminé et le lupus érythémateux cutané.
Bibliography:Application Number: CA20223209138